Functional dyspepsia of ulcer-dysmotility type: clinical incidence and therapeutic strategy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

190

HTML

1656

Tables (1-1)

196

Sum=2042

Aug 15, 1998 (publication date) through Dec 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 15, 1998; 4(4): 367-368
Published online Aug 15, 1998. doi: 10.3748/wjg.v4.i4.367

Table 1 Symptom disappearance after treatment

^aP < 0.01 vs famotidine plus cisapride group.

Citation: Wang XZ, Lin GZ. Functional dyspepsia of ulcer-dysmotility type: clinical incidence and therapeutic strategy. World J Gastroenterol 1998; 4(4): 367-368
URL: https://www.wjgnet.com/1007-9327/full/v4/i4/367.htm
DOI: https://dx.doi.org/10.3748/wjg.v4.i4.367